TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis

Hepatology

Volumn 28, Issue 3, 1998, Pages 839-842

  Charlton, Michael ^a   Adjei, Philip ^a   Poterucha, John ^a   Zein, Nizar ^a   Moore, Breanndan ^a   Therneau, Terry ^a   Krom, Ruud ^a   Wiesner, Russell ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA VIRUS; FEMALE; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; VIRUS INFECTION; VIRUS ISOLATION;

EID: 0031721880     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280335     Document Type: Article

References (16)

1. Kodali VP, Gordon SC, Silverman AL, McCray DG. Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis. Am J Gastroenterol 1994;89:1836-1839.
2. Belle SH, Beringer KC, Detre KM. An update of liver transplantation in the United States: Recipient characteristics and outcome. In: Cecka JM, Terasaki PI, eds. Clinical Transplants 1995. Los Angeles, CA: UCLA Tissue Typing Laboratory, 1996.
3. Belle SH, Beringer KC, Detre KM. Recent findings concerning liver transplantation in the United States. In: Terasaki PI, Cecka JM, eds. Clinical Transplants 1996. Los Angeles: UCLA Tissue Typing Laboratory, 1997:15-30.
4. De Felippi F, Romeo R, Rumi MG, Donato MF, Del Ninno E, Colombo M. Low prevalence of HGV-RNA in Italian patients with non - A-E chronic hepatitis [Abstract]. HEPATOLOGY 1996;24:499A.
5. Yamashita K, Oketani M, Oketani K, Yamauchi K, Sho Y, Arima T, Mawatari S, et al. Cryptogenic severe liver diseases in South Japan [Abstract]. HEPATOLOGY 1996;24:600A.
6. Hamid S, Jafri W, Khurshid M, Jarvis L, Shah H, Abbas Z, Sultana T, et al. Hepatitis G in the developing world: impact of HGV on liver disease in Pakistan [Abstract]. HEPATOLOGY 1996;24:520A.
7. Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C [Letter]. N Engl J Med 1996;334:195-196.
8. Alter MJ, Gallagher M, Morris T, Moyer LA, Meeks EL, Krawczynski KZ, Kim JP, et al. Role of hepatitis G virus in the etiology and clinical course of viral hepatitis [Abstract]. HEPATOLOGY 1996;24:247A.
9. Detre K, Belle S, Beringer K, Daily OP. Liver transplantation for fulminant hepatic failure in the United States: October 1987 through December 1991. Clin Transplant 1994;8:274-280.
10. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997;241:92-97.
11. Okamoto H, Nishizawa T, Kato N, Ukita M, Ikeda K, Miyakawa Y, Mayumi, M. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res 1998;10:1-16.
12. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes [Published erratum appears in Lancet 1993;Oct 16:342(8877): 1000] [Comments]. Lancet 1993;342:273-275.
13. Cox DR. Regression models and life tables. J Royal Stat Soc 1972;34:187-220.
14. Doi H, Apichartpiyakul C, Ohba KI, Mizokami M, Hotta H. Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6. J Clin Microbiol 1996;34:569-574.
15. Mizokami M, Gojobori T, Lau JY. Molecular evolutionary virology: its application to hepatitis C virus. Gastroenterology 1994;107:1181-1182.
16. Ohno T, Mizokami M, Tibbs CJ, Ohba K, Suzuki K, Wu RR, Nouri AKT, et al. New genotype of hepatitis C virus in South Africa. J Med Virol 1994;42:409-413.